Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bactiguard Holding ABCHIX:BACTBS 52 EV-to-OCF is 47.99 as of Aug. 10, 2026, which is 32% above its 10-year median of 36.33. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr242.71. The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Bactiguard Holding AB ranks worse than 90.15% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Bactiguard Holding AB's Enterprise Value is kr667.3 Mil.
Bactiguard Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr13.9 Mil. Therefore, Bactiguard Holding AB's EV-to-OCF for today is 47.99.
The historical rank and industry rank for Bactiguard Holding AB's EV-to-OCF or its related term are showing as below:
CHIX:BACTBs'
s EV-to-OCF Range Over the Past 10 Years
Min: -1132.82 Med: 36.33 Max: 8697.82
Current: 47.99
During the past 13 years, the highest EV-to-OCF of Bactiguard Holding AB was 8697.82. The lowest was -1132.82. And the median was 36.33.
CHIX:BACTBs's EV-to-OCF is ranked worse than 90.15% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs CHIX:BACTBs: 47.99
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bactiguard Holding AB (CHIX:BACTBs) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bactiguard Holding AB's PE Ratio (TTM) for today is calculated as:
Bactiguard Holding AB's share price for today is kr128.60.
Bactiguard Holding AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.240.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BACTBS vs ABT, SYK, MDT: EV-to-OCF Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's EV-to-OCF falls into.
Bactiguard Holding AB's current Enterprise Value is kr667.3 Mil.
Bactiguard Holding AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr13.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB (CHIX:BACTBS) has a EV-to-OCF of 47.99 as of Aug. 10, 2026. This is 32% above median its historical median of 36.33. According to the industry distribution chart, Bactiguard Holding AB ranks #769 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 90.2%.
Is Bactiguard Holding AB's EV-to-OCF too high?
Bactiguard Holding AB's current EV-to-OCF of 47.99 is 32% above median its 10-year median of 36.33. The Medical Devices & Instruments industry median EV-to-OCF is 7.82. Bactiguard Holding AB's value of 47.99 is 513.7% above this industry median. Based on the distribution chart, Bactiguard Holding AB ranks #769 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #769 out of 853 companies for EV-to-OCF. This places Bactiguard Holding AB in the lower half of its industry. The industry median EV-to-OCF is 7.82. Bactiguard Holding AB's value of 47.99 is 513.7% above this benchmark. While the company's 10-year median is 36.33 vs. the industry median of 7.82, Bactiguard Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bactiguard Holding AB's current EV-to-OCF of 47.99 is 513.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current EV-to-OCF is 47.99, which is 32% above median its own 10-year median of 36.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current EV-to-OCF of 47.99. The stock's GF Value™ is kr242.71, compared to a current price of kr128.60 — trading 47% below its estimated fair value. The current EV-to-OCF is 47.99, which is 32% above median its 10-year median of 36.33 and 513.7% above the Medical Devices & Instruments industry median of 7.82. Bactiguard Holding AB's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current EV-to-OCF is 47.99 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 47% below its estimated GF Value™ of kr242.71.
Key valuation signals for CHIX:BACTBS:
EV-to-OCF: 47.99 (32% above median its 10-year median of 36.33)
GF Value™: kr242.71 vs. price of kr128.60 (47% below fair value)
Industry Position: 513.7% above the Medical Devices & Instruments median (#769 of 853)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score
Get the complete analysis for CHIX:BACTBS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
